Test time has arrived: the first person has been treated in a highly anticipated gene therapy trial that aims to coax aged ...
Axios on MSN
Longevity medicine's do-or-die moment
The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...
For those hoping to cure death, and they are legion, a 2016 experiment at the Salk Institute for Biological Studies in San Diego has become liminal — the moment that changed everything. The experiment ...
IFLScience on MSN
World first trial to reprogram broken cells in glaucoma begins in humans – but is it just hype?
For many, it’s the ultimate dream – one which, with an exciting and controversial new gene therapy, is about to be put to the ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...
Hundreds of millions of people worldwide are affected by genetic diseases that modern medicine struggles to cure. Many of these conditions stem not from mutations but from gene silencing, where ...
Viruses that infect bacteria—known as bacteriophages—could be used in a targeted manner to combat bacterial diseases. They also play an important ecological role in global biogeochemical cycles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results